Medication-info.com Search Menu

NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA Package Insert

Status:
Prescription (Rx) Boxed warning Facts
Strength:
3 mg, 3 mg, 20 mg, 50 mg, 1 mg, 10 mcg, 155 mg, 45 mg, 32 mg, 120 mg, 450 IU, 30 IU, 100 mcg, 10 mg, 55 mg, 230 mg, 30 mg, 2 IU
Drug class:
Active ingredients:
Similar drugs:

Prescribing information (package insert) - NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA

D escripton: Nestabs DHA combination tablet-capsule for oral administration is a light pink capsule-shaped film coated tablet with a pleasant sweet flavor with WCOO1 imprinted on one side of the tablet and a enteric coated light amber soft gel capsule omega-3 fatty acid containing both DHA and EPA.

I ndications and Usage: Nestabs DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Nestabs DHA is also beneficial in improving the nutritional status of women prior to conception.

C ontraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .

W arnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

P recautions: Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. This product contains formate, which if consumed above the recommended level, could cause visual impairment and other health effects. Do not take more than the recommended amount. If you are pregnant, nursing, or taking any medications consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur. Not intended for use by persons under the age of 18.

A dverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

D osage and Administration: Nestabs DHA - One tablet and one soft gel capsule daily or as directed by a physician.

H ow Supplied: Nestabs DHA tablets for oral administration are supplied as six child-resistant blister cards containing 5 tablets and 5 softgel capsules each (NDC# 50967-317-30).

About this document

Source: FDA drug labeling via NLM DailyMed · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Blood Coagulation Factor, Phosphate Binder, Vitamin B12, Vitamin B6 Analog, Vitamin C, Vitamin D
Active ingredients Thiamine mononitrate 3 mg, Riboflavin 3 mg, Niacinamide 20 mg, Pyridoxine hydrochloride 50 mg, Folic acid 1 mg, Cyanocobalamin 10 mcg, Calcium formate 155 mg, Calcium carbonate 45 mg, Ferrous bisglycinate 32 mg, Sodium ascorbate 120 mg, Cholecalciferol 450 IU, Alpha-tocopherylquinone 30 IU, Potassium iodide 100 mcg, Zinc oxide 10 mg, Choline bitartrate 55 mg, Doconexent 230 mg, Icosapent 30 mg, Alpha-tocopherol, D- 2 IU
Dosage form Kit
Marketing status listed in the FDA NDC Directory
Company (applicant) WOMENS CHOICE PHARMACEUTICALS LLC
FDA approval UNAPPROVED DRUG OTHERUnapproved drug
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
3 mg, 3 mg, 20 mg, 50 mg, 1 mg, 10 mcg, 155 mg, 45 mg, 32 mg, 120 mg, 450 IU, 30 IU, 100 mcg, 10 mg, 55 mg, 230 mg, 30 mg, 2 IU – 1 in 1 blister pack / 4 in 1 carton NDC 50967-317-30

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.